Non-coding RNA therapeutics in the treatment of heart failure

被引:3
作者
Paterek, Aleksandra [1 ]
Zaleska-Kociecka, Marta [2 ]
Surzykiewicz, Mateusz [1 ]
Wojdynska, Zuzanna [2 ]
Leszek, Przemyslaw [2 ]
Maczewski, Michal [1 ]
机构
[1] Ctr Postgrad Med Educ, Dept Clin Physiol, Marymoncka 99-103, PL-01813 Warsaw, Poland
[2] Natl Inst Cardiol, Heart Failure & Transplantol Dept, Mech Circulatory Support & Transplant Dept, Alpejska 42, PL-04628 Warsaw, Poland
关键词
Non-coding RNA; Heart failure; Therapy; Heart failure with reduced ejection fraction; MicroRNA; ANTISENSE OLIGONUCLEOTIDES; TARGETED DELIVERY; ANIMAL-MODEL; DOUBLE-BLIND; MICRORNAS; REVEALS; ANGIOTENSINOGEN; INTERFERENCE; HYPERTROPHY; SUPPRESSION;
D O I
10.1093/ehjcvp/pvae027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Non-coding RNA (ncRNA) therapeutics can target either ncRNAs or conventional messenger RNA, offering both superior pharmacokinetics and selectivity to conventional therapies and addressing new, previously unexplored pathways. Although no ncRNA has yet been approved for the treatment of heart failure, in this review we present five most promising pathways and agents that either are in human clinical trials or offer great promise in the near future.
引用
收藏
页码:353 / 360
页数:8
相关论文
共 76 条
[11]   The Universal Definition of Heart Failure: Perspectives from Diverse Stakeholders [J].
Mentz, Robert J. ;
Lala, Anuradha .
JOURNAL OF CARDIAC FAILURE, 2021, 27 (04) :386-386
[12]   Inhibition of angiotensinogen in the treatment of hypertension [J].
Braunwald, Eugene .
EUROPEAN HEART JOURNAL, 2023, 44 (47) :4909-4910
[13]   Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses [J].
Cabili, Moran N. ;
Trapnell, Cole ;
Goff, Loyal ;
Koziol, Magdalena ;
Tazon-Vega, Barbara ;
Regev, Aviv ;
Rinn, John L. .
GENES & DEVELOPMENT, 2011, 25 (18) :1915-1927
[14]   MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways [J].
Chau, B. Nelson ;
Xin, Cuiyan ;
Hartner, Jochen ;
Ren, Shuyu ;
Castano, Ana P. ;
Linn, Geoffrey ;
Li, Jian ;
Tran, Phong T. ;
Kaimal, Vivek ;
Huang, Xinqiang ;
Chang, Aaron N. ;
Li, Shenyang ;
Kalra, Aarti ;
Grafals, Monica ;
Portilla, Didier ;
MacKenna, Deidre A. ;
Orkin, Stuart H. ;
Duffield, Jeremy S. .
SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (121)
[15]   Antisense oligonucleotides: a novel Frontier in pharmacological strategy [J].
Collotta, D. ;
Bertocchi, I. ;
Chiapello, E. ;
Collino, M. .
FRONTIERS IN PHARMACOLOGY, 2023, 14
[16]   Molecular Mechanisms of Antisense Oligonucleotides [J].
Crooke, Stanley T. .
NUCLEIC ACID THERAPEUTICS, 2017, 27 (02) :70-77
[17]   Angiotensinogen Suppression: A New Tool to Treat Cardiovascular and Renal Disease [J].
Cruz-Lopez, Edwyn O. ;
Ye, Dien ;
Wu, Congqing ;
Lu, Hong S. ;
Uijl, Estrellita ;
Mirabito Colafella, Katrina M. ;
Danser, A. H. Jan .
HYPERTENSION, 2022, 79 (10) :2115-2126
[18]   Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension [J].
Desai, Akshay S. ;
Webb, David J. ;
Taubel, Jorg ;
Casey, Sarah ;
Cheng, Yansong ;
Robbie, Gabriel J. ;
Foster, Don ;
Huang, Stephen A. ;
Rhyee, Sean ;
Sweetser, Marianne T. ;
Bakris, George L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (03) :228-238
[19]   Effect of Dapagliflozin on Cause-Specific Mortality in Patients With Heart Failure Across the Spectrum of Ejection Fraction A Participant-Level Pooled Analysis of DAPA-HF and DELIVER [J].
Desai, Akshay S. ;
Jhund, Pardeep S. ;
Claggett, Brian L. ;
Vaduganathan, Muthiah ;
Miao, Zi Michael ;
Kondo, Toru ;
Barkoudah, Ebrahim ;
Brahimi, Abdel ;
Connolly, Eugene ;
Finn, Peter ;
Lang, Ninian N. ;
Mc Causland, Finnian R. ;
McGrath, Martina ;
Petrie, Mark C. ;
McMurray, John J., V ;
Solomon, Scott D. .
JAMA CARDIOLOGY, 2022, 7 (12) :1227-1234
[20]   Long non-coding RNA: its evolutionary relics and biological implications in mammals: a review [J].
Dhanoa, Jasdeep Kaur ;
Sethi, Ram Saran ;
Verma, Ramneek ;
Arora, Jaspreet Singh ;
Mukhopadhyay, Chandra Sekhar .
JOURNAL OF ANIMAL SCIENCE AND TECHNOLOGY, 2018, 60